INTERNATIONAL JOURNAL OF ADVANCE RESEARCH
IN MULTIDISCIPLINARY

Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine disorder affecting women of reproductive age, characterized by a spectrum of symptoms including acne, hirsutism, and androgenic alopecia. These manifestations are primarily driven by hyperandrogenism, which adversely impacts the quality of life and psychological well-being of affected individuals. Antiandrogen medications have emerged as pivotal therapeutic agents in mitigating these symptoms by targeting androgen pathways. This prospective study aims to evaluate the efficacy and safety of various antiandrogen therapies in reducing dermatological and hair-related symptoms in PCOS patients. Utilizing a case study methodology, the research analyzes patient outcomes, treatment adherence, and quality of life improvements over a 12-month period. The findings indicate that antiandrogen therapies, when appropriately selected and monitored, significantly alleviate PCOS-associated symptoms, thereby enhancing patient well-being and clinical outcomes.